Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients
Alexandra Samsen, Hartmut Juhl(Dermatologikum Hamburg), Cay-Uwe von Seydewitz(Krankenhaus Reinbek - Startseite), Bernd Flath(Praxis für Hämatologie und Onkologie), Ludger Heflik(Praxis für Hämatologie und Onkologie), Wolfgang Saeger(Universität Hamburg), Eike von Leitner, C. Zornig(Israelitisches Krankenhaus), Wiebke Hollburg(Praxis für Hämatologie und Onkologie), Silvia von der Heyde, Friedrich Overkamp, Carsten Bokemeyer(Universität Hamburg), Max Graap, Alexander Stein(Universität Hamburg), Bianca Grebenstein, Axel Stang(Semmelweis University), Peter Layer(Israelitisches Krankenhaus), Kerstin A. David(University of Hawaiʻi at Mānoa), Sandra Schneider(Düsseldorf University Hospital)
Cited by 4
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Detection and quantification of mutations in the plasma of patients with colorectal tumors
|Proceedings of the National Academy of Sciences|2005|1.2k